These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25469829)

  • 21. Does Reducing Basal Insulin During Ramadan Fasting by Children and Adolescents with Type 1 Diabetes Decrease the Risk of Symptomatic Hypoglycemia?
    Deeb A; Al Qahtani N; Attia S; Al Suwaidi H; Nagelkerke N
    Diabetes Technol Ther; 2016 Sep; 18(9):539-42. PubMed ID: 27500913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.
    Siegmund T; Blankenfeld H; Schumm-Draeger PM
    Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus.
    Schwartz S; Hassman D; Shelmet J; Sievers R; Weinstein R; Liang J; Lyness W
    Clin Ther; 2004 Oct; 26(10):1663-78. PubMed ID: 15598483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine.
    Garg SK; Gottlieb PA; Hisatomi ME; D'Souza A; Walker AJ; Izuora KE; Chase HP
    Diabetes Res Clin Pract; 2004 Oct; 66(1):49-56. PubMed ID: 15364161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the User Preference and Level of Insulin Self-Administration Adherence in Young Patients With Type 1 Diabetes: Experience With Two Insulin Pen Needle Lengths.
    Al Hayek AA; Al Dawish M
    Cureus; 2020 Jun; 12(6):e8673. PubMed ID: 32699673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT.
    Strojek K; Bebakar WM; Khutsoane DT; Pesic M; Smahelová A; Thomsen HF; Kalra S
    Curr Med Res Opin; 2009 Dec; 25(12):2887-94. PubMed ID: 19821654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear.
    Rini CJ; McVey E; Sutter D; Keith S; Kurth HJ; Nosek L; Kapitza C; Rebrin K; Hirsch L; Pettis RJ
    Drug Deliv Transl Res; 2015 Aug; 5(4):332-45. PubMed ID: 26037035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injection Technique and Pen Needle Design Affect Leakage From Skin After Subcutaneous Injections.
    Præstmark KA; Stallknecht B; Jensen ML; Sparre T; Madsen NB; Kildegaard J
    J Diabetes Sci Technol; 2016 Jul; 10(4):914-22. PubMed ID: 26798083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth.
    Bochanen N; Decochez K; Heleu E; Cuypers J; Vercammen C; Coremans P; Vanhaverbeke G; Shadid S; Keymeulen B; Bolsens N; De Block C
    Diabet Med; 2022 Jan; 39(1):e14672. PubMed ID: 34407260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effects of a new 32-gauge × 4-mm pen needle and a 32-gauge × 6-mm pen needle on glycemic control, safety, and patient ratings in Japanese adults with diabetes.
    Miwa T; Itoh R; Kobayashi T; Tanabe T; Shikuma J; Takahashi T; Odawara M
    Diabetes Technol Ther; 2012 Dec; 14(12):1084-90. PubMed ID: 23030357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Errors in insulin treatment management and risk of lipohypertrophy.
    Pozzuoli GM; Laudato M; Barone M; Crisci F; Pozzuoli B
    Acta Diabetol; 2018 Jan; 55(1):67-73. PubMed ID: 29098390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of insulin diluent leakage postinjection using two different needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus.
    Ignaut DA; Fu H
    J Diabetes Sci Technol; 2012 Mar; 6(2):389-93. PubMed ID: 22538152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin blood perfusion and cellular response to insertion of insulin pen needles with different diameters.
    Præstmark KA; Jensen CB; Stallknecht B; Madsen NB; Kildegaard J
    J Diabetes Sci Technol; 2014 Jul; 8(4):752-9. PubMed ID: 24876418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.
    Gibney MA; Arce CH; Byron KJ; Hirsch LJ
    Curr Med Res Opin; 2010 Jun; 26(6):1519-30. PubMed ID: 20429833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subjective Discomfort during Botulinumtoxin Injections Dependent on Injection Site and Needle Size: A Comparison Between 30G, 33G and 34G Needles.
    Kämmerer TA; Bertlich R; Hartmann D; Jakob M; Weiss BG; Bertlich I; Ihler F; Wiggenhauser PS; Bertlich M
    Aesthetic Plast Surg; 2024 Jul; 48(13):2528-2535. PubMed ID: 38441599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. User experiences with second-generation 32-gauge × 4 mm vs. thinner comparator pen needles: prospective randomized trial.
    Gibney MA; Fitz-Patrick D; Klonoff DC; Whooley S; Lu B; Yue W; Glezer S
    Curr Med Res Opin; 2020 Oct; 36(10):1591-1600. PubMed ID: 32723109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of distance from skin surface to muscle for evaluation of the risk of inadvertent intramuscular insulin injection at potential injection sites among patients attending a tertiary care children's hospital in Sri Lanka-an observational study.
    Kodikara SKYI; Kalubowila J; Atapattu N; Warapitiya DS; Wijayabandara MDMS; Jayasekara LMDT; Arunthavanathan A; Kempitiya BCTANWMRCS; de Silva KSH; de Abrew K
    Arch Pediatr; 2020 Jul; 27(5):244-249. PubMed ID: 32461034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes.
    Hirsch L; Gibney M; Berube J; Manocchio J
    J Diabetes Sci Technol; 2012 Mar; 6(2):328-35. PubMed ID: 22538142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.